Dozun Belirlenmesi ve Reçeteleme

Ahmed AR, Obilana A, Lappin D. Renal Replacement Therapy in the Critical Care Setting. Crit Care Res Pract 2019;2019:6948710.

Bagsaw S. M., Chakravarthi M. R., Ricci Z., et al. Precision Continous Renal Replacement Thherapy and Solute Control. Blood Purif 2016;42(3):238-47.

Baldwin I., Jones D., Carty P., et al. Continous Renal Replacement Therapy without Anticoagulation: Top Ten Tips to Prevent Clotting. Blood Pruf 2020;49(4):490-5.

Bellomo R., Cass A., Cole L., et al. Intesity of Continuous Renal Replacement Therapy in Criticallill Patients. N Engl J Med 2009:361:1627-38.

Brunet S., Leblanc M., Geadah D., et al. Diffisuve and Convective Solute Clerances During Continous Renal Replacement Therapy at Various Dialysate and Ultrafitration Flow Rate. Am J Kidney Dis1999;34(3):486-92.

Chacko J. Renal Replacement Therapy in The Intensive Care Unıt. Indıan J Crit Care Med 2008;12(4):174-80.

Fayad A., Buamscha D., Ciapponi A. Intensity of Continuous Renal Replacement Therapy for Akut Kidney Injury. Database Syst Rev 2016;10(10)CD010613.

Fealy N., Aitken L., Toit E., et al. Faster Blood Flow Rate Does Not Improve Circut Life in CONTİNOUS Renal Replacement Therapy. Crit Care Med 2017;45(10):1018-1025

Harada M., Ooki M., Kohasi K., et al. Clinişcal Survey of Decreased Blood Flow Rate in Continous Renal Replacement Therapy . Crit Care Med 2019;2019:2842313.

Joaniidis M., Oudesmans-vanstraaten HM. Clinical Review: Patency of The Circut Life in Continos Renal Replacement Therapy. Crit Care. 2007;11(4)218.

Karkar A., Ronco C. Prescription of CRRT: a pathway to optimize therapy. Annals of Intensive Care 2020;10(1):32.

Leypoldt JK., Kamerath CD., Gilson JF., et al. Dialyzer Clerances and Mass Transfer Area Coefficients for Small Solutes at Low Dialysate Flow Rates. Asio J 2006;52(4)404-9.

Palevsky PM., Zang JH., O’Connor TZ., et al. Intensıty of Renal Support in Critically Patients with Acute Kidney Injury. N Engl J Med 2008;359(1):7-20.

Prowe JR., Schendier A., Bellomo R., et al. Optimal Dose of Continous Renal Replacement Therapy in Acute Kidney Injury. CRİT Care 2011;15(2):207.

Relton S., Greenberg A., Palevsky PM., Dialysate and Blood Flow Dependence of Diffusive Solute Clerance During CVVHD. Asaio J 1992;38(3)M691-6.

Ronco C., Bellomo R., Homel P., et al. Effects of Different Doses in Cntinous Veno-venous Heamofiltration on Outcome of Cute Renal Failure. Lancet 2000;356:26-30.

Ronco C., Bellomo R., Kellum Aj., Continous Renal Replcement Therapy. Oxford University Press 2010 chapter 16(129-134).

Ronco C., Ghezzi PM., Brendolan A.,et al. The Haemodialysis System:Basic Mechanisms of Water and Solute Transport in Extracorporeal Renal Replacement Therapies. Nephrol Dial Transplant 1998;13Suppl 6:3-9.

Schneider A., Journois D., Rimmele T. Complications of Regional Citrate Anticoagulation: Accumulation or Overload. Crit Care 2017;21(1):218.

Theranian S., Shawwa K., Kashani KB. Net Ultrafiltration Rate and Its Impact on Mortality in Patients with Acute Kidney Injury Receiving Continous Renal Replacement Therapy. Clinical Kidney Journal 2021;14(2):564-9.

Uchino S., Fealy N., Baldwin I., et al. Pre-dilution vs. Post-dilution During Continous Veno-venous Haemofiltration: Impact on Filter Life and Azotemic Control. Nephron Clin Pract 2003;94(4)c94-8.

Ahmed AR, Obilana A, Lappin D. Renal Replacement Therapy in the Critical Care Setting. Crit Care Res Pract 2019;2019:6948710.

Bagsaw S. M., Chakravarthi M. R., Ricci Z., et al. Precision Continous Renal Replacement Thherapy and Solute Control. Blood Purif 2016;42(3):238-47.

Baldwin I., Jones D., Carty P., et al. Continous Renal Replacement Therapy without Anticoagulation: Top Ten Tips to Prevent Clotting. Blood Pruf 2020;49(4):490-5.

Bellomo R., Cass A., Cole L., et al. Intesity of Continuous Renal Replacement Therapy in Criticallill Patients. N Engl J Med 2009:361:1627-38.

Brunet S., Leblanc M., Geadah D., et al. Diffisuve and Convective Solute Clerances During Continous Renal Replacement Therapy at Various Dialysate and Ultrafitration Flow Rate. Am J Kidney Dis1999;34(3):486-92.

Chacko J. Renal Replacement Therapy in The Intensive Care Unıt. Indıan J Crit Care Med 2008;12(4):174-80.

Fayad A., Buamscha D., Ciapponi A. Intensity of Continuous Renal Replacement Therapy for Akut Kidney Injury. Database Syst Rev 2016;10(10)CD010613.

Fealy N., Aitken L., Toit E., et al. Faster Blood Flow Rate Does Not Improve Circut Life in CONTİNOUS Renal Replacement Therapy. Crit Care Med 2017;45(10):1018-1025

Harada M., Ooki M., Kohasi K., et al. Clinişcal Survey of Decreased Blood Flow Rate in Continous Renal Replacement Therapy . Crit Care Med 2019;2019:2842313.

Joaniidis M., Oudesmans-vanstraaten HM. Clinical Review: Patency of The Circut Life in Continos Renal Replacement Therapy. Crit Care. 2007;11(4)218.

Karkar A., Ronco C. Prescription of CRRT: a pathway to optimize therapy. Annals of Intensive Care 2020;10(1):32.

Leypoldt JK., Kamerath CD., Gilson JF., et al. Dialyzer Clerances and Mass Transfer Area Coefficients for Small Solutes at Low Dialysate Flow Rates. Asio J 2006;52(4)404-9.

Palevsky PM., Zang JH., O’Connor TZ., et al. Intensıty of Renal Support in Critically Patients with Acute Kidney Injury. N Engl J Med 2008;359(1):7-20.

Prowe JR., Schendier A., Bellomo R., et al. Optimal Dose of Continous Renal Replacement Therapy in Acute Kidney Injury. CRİT Care 2011;15(2):207.

Relton S., Greenberg A., Palevsky PM., Dialysate and Blood Flow Dependence of Diffusive Solute Clerance During CVVHD. Asaio J 1992;38(3)M691-6.

Ronco C., Bellomo R., Homel P., et al. Effects of Different Doses in Cntinous Veno-venous Heamofiltration on Outcome of Cute Renal Failure. Lancet 2000;356:26-30.

Ronco C., Bellomo R., Kellum Aj., Continous Renal Replcement Therapy. Oxford University Press 2010 chapter 16(129-134).

Ronco C., Ghezzi PM., Brendolan A.,et al. The Haemodialysis System:Basic Mechanisms of Water and Solute Transport in Extracorporeal Renal Replacement Therapies. Nephrol Dial Transplant 1998;13Suppl 6:3-9.

Schneider A., Journois D., Rimmele T. Complications of Regional Citrate Anticoagulation: Accumulation or Overload. Crit Care 2017;21(1):218.

Theranian S., Shawwa K., Kashani KB. Net Ultrafiltration Rate and Its Impact on Mortality in Patients with Acute Kidney Injury Receiving Continous Renal Replacement Therapy. Clinical Kidney Journal 2021;14(2):564-9.

Uchino S., Fealy N., Baldwin I., et al. Pre-dilution vs. Post-dilution During Continous Veno-venous Haemofiltration: Impact on Filter Life and Azotemic Control. Nephron Clin Pract 2003;94(4)c94-8.